Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Equity (2016 - 2025)

Standard Biotools (LAB) has disclosed Return on Equity for 15 consecutive years, with 0.27% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 18.0% to 0.27% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.27%, a 18.0% decrease, with the full-year FY2024 number at 0.86%, down 122.0% from a year prior.
  • Return on Equity was 0.27% for Q3 2025 at Standard Biotools, down from 0.26% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 21.26% in Q2 2022 to a low of 2.0% in Q1 2022.
  • A 5-year average of 0.92% and a median of 0.26% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: surged 2178bps in 2022, then crashed -2211bps in 2023.
  • Standard Biotools' Return on Equity stood at 0.61% in 2021, then soared by 136bps to 0.22% in 2022, then surged by 32bps to 0.29% in 2023, then crashed by -186bps to 0.25% in 2024, then decreased by -8bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Equity are 0.27% (Q3 2025), 0.26% (Q2 2025), and 0.26% (Q1 2025).